Now Credit Card Companies Want Your DNA
By Martha C. White,
Time: Moneyland
| 10. 27. 2011
A
Wall Street Journal article earlier this week reported that Visa and MasterCard are exploring new ways to take data about your buying habits in the brick-and-mortar world and let online marketers use that information to target you with ads when you browse the web. But buried a little ways down in the article are some details that are considerably more alarming. Visa, the article says, wants access to everything from your insurance claim history to your Facebook friends list to your DNA. Yes, you read that right:
According to a Visa patent application published in April, the company sees potential to use a wide array of personal details to create profiles that could be used for ad targeting well beyond shopping details. It describes the possibility of also using “information from social network websites, information from credit bureaus, information from search engines, information about insurance claims, information from DNA databanks,” and other sources.
This is a huge can of worms, warns Lillie Coney, associate director of the Electronic Privacy Information Center. “This is going to be problematic,” she says...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Patrick Foong, BioNews | 11.03.2025